Erratum: Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate (Biochemical and Biophysical Research Communications (2004) 318 (862-867) DOI: 10.1016/j.bbrc.2004.04.098);Characterization of SARS main protease and inhibitor assay using a fluorogenic substrate

Biochemical and Biophysical Research Communications

Volumn 318, Issue 4, 2004, Pages 862-867

  Kuo, Chih Jung ^a   Chi, Ya Hui ^b   Hsu, John T A ^b   Liang, Po Huang ^a  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Chymotrypsin; Cysteine protease; Fluorescence resonance energy transfer; Fluorogenic substrate; Inhibitor screening; SARS protease

Indexed keywords

DIMER; ENZYME INHIBITOR; MONOMER; PEPTIDE; PROTEINASE;

ARTICLE; CATALYSIS; DISSOCIATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME SUBSTRATE; NONHUMAN; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME;

CORONAVIRUS; ESCHERICHIA COLI; SARS CORONAVIRUS;

EID: 2442435903     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.06.001     Document Type: Erratum

References (21)

1. Drosten C., Gunther S., Preiser W., van der Werf S., Brodt H.R., Becker S., Rabenau H., Panning M., Kolesnikova L., Fouchier R.A., Berger A., Burguiere A.M., Cinatl J., Eickmann M., Escriou N., Grywna K., Kramme S., Manuguerra J.C., Muller S., Rickerts V., Sturmer M., Vieth S., Klenk H.D., Osterhaus A.D., Schmitz H., Doerr H.W. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N. Engl. J. Med. 348:2003;1967-1976
2. Ksiazek T.G., Erdman D., Golsmith C.S., Zaki S.R., Peret T., Emery S., Tong S., Urbani C., Comer J.A., Lim W., Rollin P.E., Dowell S.F., Ling A.E., Humphrey C.D., Shieh W.J., Guarner J., Paddock C.D., Rota P., Fields B., DeRisis J., Yang J.Y., Cox N., Hughes J.M., LeDue J.W., Bellini W.J., Anderson L.J.A. A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348:2003;1953-1966
3. Fouchier R.A., Kuiken T., Schutten M., van Amerongen G., van Doornum G.J., van den Hoogen B.G., Peiris M., Lim W., Stohr K., Osterhaus A.D. Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 423:2003;240
4. Peiris J.S., Lai S.T., Poon L.L., Guan Y., Yam L.Y., Lim W., Nicholls J., Yee W.K., Yan W.W., Cheung M.T., Cheng V.C., Chan K.H., Tsang D.N., Yung R.W., Ng T.K., Yuen K.Y. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet. 361:2003;1319-1325
5. Rota P.A., Oberste M.S., Monroe S.S., Nix W.A., Campagnoli R., Icenogle J.P., Penaranda S., Bankamp B., Maher K., Chen M.-H., Tong S., Tamin A., Lowe L., Frace M., Derisi J.L., Chen Q., Wang D., Erdman D.D., Peret T.C.T., Burns C., Ksiazek T.G., Rollin P.E., Sanchez A., Liffick S., Holloway B., Limor J., McCaustland K., Olsen-Rasmussen M., Fouchier R., Gunther S., Osterhaus A.D.M.E., Drosten C., Pallansch M.A., Anderson L.J., Bellini W.J. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:2003;1394-1399
6. Marra M.A., Jones S.J.M., Astell C.R., Holt R.A., Brooks-Wilson A., Butterfield Y.S.N., Khattra J., Asano J.K., Barber S.A., Chan S.Y., Cloutier A., Coughlin S.M., Freeman D., Girn N., Griffith O.L., Leach S.R., Mayo M., McDonald H., Montgomery S.B., Pandoh P.K., Petrescu A.S., Robertson G., Schein J.E., Siddiqui A., Smailus D.E., Stott J.M., Yang G.S., Plummer F., Andonov A., Artsob H., Bastien N., Bernard K., Booth T.F., Bowness D., Czub M., Drebot M., Fernando L., Flick R., Garbutt M., Gray M., Grolla A., Jones S., Feldmann H., Meyers A., Kabani A., Li Y., Normand S., Stroher U., Tipples G.A., Tyler S., Vogrig R., Ward D., Watson B., Brunham R.C., Krajden M., Petric M., Skowronski D., Upton C., Roper R. The Genome sequence of the SARS-associated coronavirus. Science. 300:2003;1399-1404
7. Ruan Y.J., Wei C.L., Ee A.L., Vega V.B., Thoreau H., Su S.T., Chia J.M., Ng P., Chiu K.P., Lim L., Zhang T., Peng C.K., Lin E.O., Lee N.M., Yee S.L., Ng L.F., Chee R.E., Stanto L.W., Long P.M., Liu E.T. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet. 361:2003;1779-1785
8. S.H. Yeh, H.Y. Wang, C.Y. Tsai, C.L. Kao, J.Y. Yang, H.W. Liu, I.J. Su, S.F. Tsai, D.S. Chen, P.J. Chen, The National Taiwan University SARS Research Team, D.S. Chen, Y.T. Lee, C.M. Teng, P.C. Yang, H.N. Ho, P.J. Chen, M.F. Chang, J.T. Wang, S.C. Chang, C.L. Kao, W.K. Wang, C.H. Hsiao, P.R. Hsueh, Characterization of severe acute respiratory syndrome coronavirus genomes in Taiwan: molecular epidemiology and genome evolution, Proc. Natl. Acad. Sci. USA 101 (2004) 2542-2547
9. Anand K., Ziebuhr J., Wadhwani P., Mesters J.R., Hilgenfeld R. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 300:2003;1763-1767
10. Yang H., Yang M., Ding Y., Liu Y., Lou Z., Zhou Z., Sun L., Mo L., Ye S., Pang H., Gao G.F., Anand K., Bartlam M., Hilgenfeld R., Rao Z. The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proc. Natl. Acad. Sci. USA. 100:2003;13190-13195
11. Chou K.C., Wei D.Q., Zhong W.Z. Binding mechanism of coronavirus main proteinase with ligands and its implication to drug design against SARS. Biochem. Biophys. Res. Commun. 308:2003;148-151
12. Li W.H., Moore M.J., Vasilieva N., Sui J., Wong S.K., Berne M.A., Somasundaran M., Sullivan J.L., Luzuriaga K., Greenough T.C., Choe H., Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 426:2003;450-454
13. Dales N.A., Gould A.E., Brown J.A., Calderwood E.F., Guan B., Minor C.A., Gavin J.M., Hales P., Kaushik V.K., Stewart M., Tummino P.J., Vickers C.S., Ocain T.D., Patane M.A. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 124:2002;11852-11853
14. Huang L., Sexton D.J., Skogerson K., Devlin M., Smith R., Sanyal I., Parry T., Kent R., Enright J., Wu Q., Conley G., DeOliveira D., Morganelli L., Ducar M., Wescott C.R., Ladner R.C. Novel peptide inhibitors of angiotensin-converting enzyme 2. J. Biol. Chem. 278:2003;15532-15540
15. Fan K., Wei P., Feng Q., Chen S., Huang C., Ma L., Lai B., Pei J., Liu Y., Chen J., Lai L. Biosynthesis, purification, and substrate specificity of severe acute respiratory syndrome coronavirus 3C-like proteinase. J. Biol. Chem. 279:2004;1637-1642
16. Matayoshi E.D., Wang G.T., Krafft G.A., Erickson J. Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science. 247:1990;954-958
17. Liang P.H., Brun K.A., Field J.A., O'Donnell K., Doyle M.L., Green S.M., Baker A.E., Blackburn M.N., Abdel-Meguid S.S. Site-directed mutagenesis probing the catalytic role of arginines 165 and 166 of human cytomegalovirus protease. Biochemistry. 37:1998;5923-5929
18. Chen Y.H., Chen A.P.-C., Chen C.T., Wang A.H.-J., Liang P.H. Probing the conformational change of Escherichia coli undecaprenyl pyrophosphate synthase during catalysis using an inhibitor and tryptophan mutants. J. Biol. Chem. 277:2002;7369-7376
19. Sun H., Luo H., Yu C., Sun T., Chen J., Peng S., Qin J., Shen J., Yang Y., Xie Y., Chen K., Wang Y., Shen X., Jiang H. Molecular cloning, expression, purification, and mass spectrometric characterization of 3C-like protease of SARS coronavirus. Protein Expr. Purif. 32:2004;302-308
20. Khayat R., Batra R., Bebernitz G.A., Olson M.W., Tong L. Characterization of the monomer-dimer equilibrium of human cytomegalovirus protease by kinetic methods. Biochemistry. 43:2004;316-322
21. Anand K., Palm G.J., Mesters J.R., Siddell S.G., Ziebuhr J., Hilgenfeld R. Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J. 21:2002;3213-3224